May 17, 2020

How To Navigate the Changing Health Care Real Estate Market

Hospital Finance
M&A
Management
Health Care Real Estate
Admin
6 min
When designing and constructing facilities, flexibility should be a key driver.
While the rollout of the Affordable Care Act (ACA) has garnered a lot of attention, there are significant trends associated with its implementation that...

While the rollout of the Affordable Care Act (ACA) has garnered a lot of attention, there are significant trends associated with its implementation that are impacting healthcare real estate. 

The first trend is focused on numbers, specifically the estimated 32 million new patients that will be covered under the ACA. Newly insured patients are not the only surge on the horizon. The senior population aged 65 and over is projected to increase by 79.2 percent through 2030. This “double hit” increase in patients will place a strain on aging hospital facilities and infrastructure already stretched to the breaking point. Can your real estate portfolio handle the influx of new patients?

The second trend is the increase in mergers and acquisitions by healthcare organizations. Motivated in large part by the desire to capture more market share, the healthcare competitive landscape has intensified significantly and facilities are becoming increasingly important to attracting patients and physicians. How can health systems keep up?

Finally, the steady march of technology promises to continue unabated. Due to the ACA and related incentives regarding electronic medical records, combined with advancements made in telemedicine - IT support and capacity have become critical drivers in the healthcare real estate market for both new and renovated medical facilities.  Can your facilities support the expanded IT requirements?

Do you have answers to the questions posed above? With pressure on your bottom line due to changing reimbursements and increased competition, many hospitals are taking a closer look at their real estate portfolio and facilities in an effort to control costs in response to revenue constraints and operating cost pressure.  

What to Look For in a Health Care Architect and Developer

The passage and implementation of the ACA has been responsible for a boom in the healthcare industry. As a result, all types of firms are trying to break into the healthcare market. Just because someone can develop, design and build a commercial office building, that does not mean they have the expertise and experience to guide you through the design of today’s medical facilities. That is why you need to retain professionals who bring extensive healthcare knowledge and experience. 

Your developer must understand the community context and have a firm grasp of your competition as well as understand the benefit of different leasing and purchasing arrangements. Your architect must offer an extensive portfolio of healthcare projects of all types and price points and recognize the importance of designing to support your brand. It is important that they understand the local zoning and code requirements, as many have changed with recent updates to the codes. 

It is important that both the developer and architect have a proven process for engaging stakeholders across the spectrum to achieve consensus on goals. If you utilize a lease-back arrangement, it is important that your architect understands the nuances of programming for users and healthcare institutions and balance that with the needs of the developer, and contractor to design a building that serves the needs of the hospital and patients for a price that fits within the lease structure. 

Changing Market Impacts Facility Design

The Urban Land Institute estimates that 64 million square feet of additional medical office space will be required during the next decade to meet the increased demand, and it will cost more to construct. According to REED Construction, the average cost of a medical office building across 25 metropolitan markets last year came in at over $240 per square foot, with New York, San Francisco, Boston, Chicago and Philadelphia having the highest medical office building costs at $257 to $303 per square foot. Hospitals can affect those costs by understanding how the market is impacting medical facility design.

The types of services being offered in an outpatient setting have increased. As a result, the complexity of the environments required to support these services has increased exponentially. New models of multi-disciplinary care are evolving to support Accountable Care Organizations, the Medical Home and other evolving care models. As a result, the standard 96’ x 200’ floor plate may not be appropriate. 

Adjacencies of key departments in ambulatory/surgical facilities require complex building infrastructure and may require MEP services enhanced with additional capacity and redundancy. Integration of physician practices can reduce duplication of services/resources/space/personnel resulting in cost savings. Design should also support an environment that facilitates information sharing and cross-referrals. 

Patient satisfaction is becoming critical for full reimbursement – col-locating services in one place is a key patient satisfier. Streamlining the check-in and in-take process through features such as kiosks and pre-admission registration has changed the design of waiting rooms.

With antiquated facilities on hospital campuses, many organizations are looking to move as many services to newer facilities, sometimes choosing to use the older spaces for post acute care. With the increased focus on preventative care, the types of services being offered by traditional physician practices is expanding and now feature wellness elements such as fitness, nutrition, counseling and preventative screening.

Facilities are being placed in retail areas in the suburbs to provide access and convenience for patients, as well as extending brand recognition for the system. Many healthcare organizations are looking at non-traditional real estate such as abandoned “big box” retail stores and repurposing general office buildings. 

New Real Estate Options for Hospitals

While the greatest monthly expense most successful medical organizations have is employment, the second is real estate. With that in mind, having a trusted real estate advisor reviewing your organization’s real estate usage and options could contribute to a healthier bottom line. With the numerous market, regulatory and reimbursement changes of the past year, a review of the following areas by a developer focused on the healthcare market could provide significant savings.

Does your ambulatory portfolio and hospital location support your strategic plan? What assets are underperforming or have become obsolete? Return on assets in healthcare lags virtually every other industry.

Due to the increase in hospital-employed physicians and the uptick in acquisition of physician practices by hospitals, many hospitals have seen their lease management activities increase rapidly and are outsourcing lease administration.

As more physician practices merge, in an effort to control their finances, shorter leases are becoming more common.

Stark and Anti-Kickback Statute laws have been in place for over 20 years, however following the ACA implementation, they have become more stringent and enforced with more vigilance.  Many healthcare organizations lack the specialized expertise to ensure that self reporting is in place so that CMS reimbursements will not be jeopardized. 

Strategies to Stay Ahead of the Curve

As the medical and healthcare industry continues to evolve, there are strategies that your developer/real estate representative and architect can utilize to help you remain on an appropriate course. When designing and constructing facilities, flexibility should be a key driver. Modalities of care are changing rapidly and your facilities will need to respond just as quickly. 

Consider standardization wherever possible so your facilities can be easily, and more cost effectively adapted to other uses. Also, consider investing in the design of a prototype for your ambulatory care and medical facilities; there is no need to reinvent the wheel with each project.  Determine what works for your organization and replicate it across your service area. A side benefit: increased brand recognition and speed to market.

Finally, manage your real estate and facility assets wisely. Determine if you can support the staffing levels to handle the increased complexity of leases, ROI and asset management so that your facilities are contributing profitably to your bottom line.  If not, consider hiring specialists who can. 

With offices in New York, Pennsylvania, Ohio, Texas, Florida and Washington, DC, Array Architects is currently assisting clients across the country with a variety of projects to update their real estate portfolio to ensure the best return on investments. With 30 years of exclusively healthcare planning and design experience, Array brings the users’ perspectives along with knowledge of life-cycle costs, appropriate/durable materials and, sustainable systems to keep the building efficient for the long-term.

Noah Tolson, Array Architects' Planning Practice Area Leader, can be reached at [email protected] or (610) 270-0599. Read more from Noah at http://blog.array-architects.com/kc/author/noah-tolson.

Share article

Jun 22, 2021

Bachem turns 50 - a timeline

pharma
supplychain
peptides
medication
3 min
As Bachem turns 50, we take a look at the company's history

Bachem, a supplier to pharmaceutical and biotechnology companies worldwide, is celebrating its 50th anniversary this month. We take a look at the Swiss company's history.  

1971 - beginnings

Bachem is founded by entrepreneur Peter Grogg in Liestal, a small town near Basel in Switzerland. Grogg started the firm with just two employees, and with a focus on peptide synthesis - peptides are composed of amino acids that have a variety of functions treating health conditions such as cancer and diabetes. 

1977 - 1981 - early growth

Bachem moves its headquarters to the Swiss town of Bubendorf, with eight employees. In 1978 the company produces peptides for use in medicines for the first time. In 1981 production capacity triples and the workforce grows to 150. 

 1987 - 1996 - worldwide expansion

The company expands into the US with Bachem Bioscience, Inc. in Philadelphia. To strengthen its presence in Europe, Bachem opens sales and marketing centres in Germany in 1988. 

Further sales centres open in France in 1993. By 1995 the company employs 190 people. In 1996 it acquires the second largest manufacturer of peptides in the world and forms Bachem California with a site in Torrance. 

 1998 - 2003 - Bachem goes public

Bachem company goes public and lists shares on the Swiss Stock Exchange. Further acquisitions include Peninsula Laboratories, Inc, based in California, and  Sochinaz SA, a Swiss-based manufacturer of active pharmaceutical ingredients.  By 2001, the company has 500 employees and sales reach 141 million CHF.

In 2003 the organisation is given a new legal holding structure to support its continued growth, which remains in place to this day. 

2007 - 2013 - acquisitions

Bachem acquires a brand by Merck Biosciences for ready-to-use clinical trial materials and related services. 

In 2013, together with GlyTech, Inc. Bachem announces the development of a new amino acid that can help to treat multiple sclerosis, with a world market of more than $4 billion. 

In 2015 it acquires the American Peptide Company (APC), which becomes integrated into Bachem Americas. 

2016 - 2019 - a global leader

In 2016 the group opens a new building dedicated to R&D projects and small series production in Bubendorf. With a total of 1,022 employees, the workforce exceeds the 1,000 mark for the first time in the company’s history. Sales are over the 200 million mark for the first time at 236.5 million CHF.
Bachem expands into Asia with the establishment of a new company in Tokyo called Bachem Japan K.K. 

By 2019 Bachem has a growing oligonucleotide portfolio - these are DNA molecules used in genetic testing, research, and forensics. It is hoped this will become a significant product range in the future. 

2020 - COVID-19

Despite the COVID-19 pandemic, Bachem secures its supply of active ingredients, and even increases it in critical areas. Sales exceed the 400 million Swiss franc mark for the first time, and  272 new employees are hired.  

2021 - a milestone anniversary

Bachem celebrates its 50th anniversary and position as a global leader in the manufacture of peptides. While it  remains headquartered in Bubendorf, the company employs 1,500 people at six locations worldwide. In the next five years there are  plans to continue expanding. 

Commemorating the company's anniversary, Kuno Sommer, Chairman of the Board of Directors, said: "Bachem's exceptional success story from a small laboratory to a global market leader is closely linked to Peter Grogg's values, and has been shaped by innovation, consistent quality and cost awareness, as well as by entrepreneurial vision."

Share article